Stryker has recently agreed to sell its US spinal implants business to the Viscogliosi Brothers and the newly formed company will be VB Spine.
This move is expected to enable its major competitors to strengthen their position in the US spinal fusion market, which was worth an estimated $5.7 billion in 2024 and is expected to reach $6.7 billion in 2034 with a compound annual growth rate (CAGR) of 1.64%, according to data and analytics company, GlobalData.
Stryker occupies a relatively small portion of the US spinal fusion market, making up approximately 9.1%, and has experienced relatively slow growth since